| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALEXION PHARMACEUTIC | 223,082 | 26,047,000 | 4.63% | ||
| 2 | GILEAD SCIENCES INC | 240,000 | 20,021,000 | 3.56% | ||
| 3 | CELGENE CORP | 199,000 | 19,627,000 | 3.49% | ||
| 4 | BIOGEN INC | 80,000 | 19,346,000 | 3.44% | ||
| 5 | LILLY ELI & CO | 235,000 | 18,506,000 | 3.29% | ||
| 6 | REGENERON PHARMACEUTICALS | 49,500 | 17,287,000 | 3.07% | ||
| 7 | INCYTE | 170,000 | 13,597,000 | 2.41% | ||
| 8 | PFIZER INC | 375,000 | 13,204,000 | 2.34% | ||
| 9 | CIGNA CORPORATION | 99,000 | 12,671,000 | 2.25% | ||
| 10 | ALLERGAN PLC | 52,000 | 12,017,000 | 2.13% | ||
| 11 | UNITEDHEALTH GROUP INC | 85,000 | 12,002,000 | 2.13% | ||
| 12 | BIOMARIN | 150,000 | 11,670,000 | 2.07% | ||
| 13 | CVS HEALTH CORP | 120,000 | 11,489,000 | 2.04% | ||
| 14 | ABIOMED INC | 105,000 | 11,475,000 | 2.04% | ||
| 15 | MEDTRONIC PLC | 127,000 | 11,020,000 | 1.96% | ||
| 16 | ALNYLAM PHARMACEUTICALS INC | 195,000 | 10,821,000 | 1.92% | ||
| 17 | BRISTOL MYERS SQUIBB CO | 137,000 | 10,076,000 | 1.79% | ||
| 18 | ENDO INTL | 635,200 | 9,903,000 | 1.76% | ||
| 19 | JAZZ PHARMACEUTICALS PLC SHS USD | 70,000 | 9,892,000 | 1.76% | ||
| 20 | AMGEN INC | 61,500 | 9,357,000 | 1.66% | ||
| 21 | EXPRESS SCRIPTS HLDG CO | 116,000 | 8,793,000 | 1.56% | ||
| 22 | ZIMMER BIOMET HLDGS INC | 71,000 | 8,547,000 | 1.52% | ||
| 23 | AETNA INC NEW | 67,000 | 8,183,000 | 1.45% | ||
| 24 | CEPHEID | 260,000 | 7,995,000 | 1.42% | ||
| 25 | CENTENE CORP DEL | 111,712 | 7,973,000 | 1.42% | ||
| 26 | HCA HOLDINGS INC | 100,000 | 7,701,000 | 1.37% | ||
| 27 | EDWARDS LIFESCIENCES CORP | 70,000 | 6,981,000 | 1.24% | ||
| 28 | NEKTAR THERAPEUTICS COM | 470,000 | 6,688,000 | 1.19% | ||
| 29 | CARDINAL HEALTH INC | 82,000 | 6,397,000 | 1.14% | ||
| 30 | EXELIXIS INC | 800,000 | 6,248,000 | 1.11% | ||
| 31 | HOLOGIC INC | 180,000 | 6,228,000 | 1.11% | ||
| 32 | CENCORA | 78,000 | 6,187,000 | 1.10% | ||
| 33 | HORIZON PHARMA PLC | 370,000 | 6,094,000 | 1.08% | ||
| 34 | LABORATORY CORP AMER HLDGS | 45,000 | 5,862,000 | 1.04% | ||
| 35 | ALKERMES PLC SHS | 135,599 | 5,861,000 | 1.04% | ||
| 36 | MEDNAX INC | 80,000 | 5,794,000 | 1.03% | ||
| 37 | SUPERNUS PHARMACEUTICALS INC COM | 280,000 | 5,704,000 | 1.01% | ||
| 38 | MCKESSON CORP | 30,000 | 5,600,000 | 0.99% | ||
| 39 | WALGREENS BOOTS ALLIANCE INC | 65,300 | 5,438,000 | 0.97% | ||
| 40 | ENDOLOGIX INC | 435,000 | 5,420,000 | 0.96% | ||
| 41 | HUMANA | 30,000 | 5,396,000 | 0.96% | ||
| 42 | Lion Biotechnologies | 650,000 | 5,265,000 | 0.93% | ||
| 43 | ANTHEM INC | 40,000 | 5,254,000 | 0.93% | ||
| 44 | VERTEX PHARMACEUT | 60,000 | 5,161,000 | 0.92% | ||
| 45 | MEDIVATION INC | 80,000 | 4,824,000 | 0.86% | ||
| 46 | CERNER CORP | 81,000 | 4,747,000 | 0.84% | ||
| 47 | ARIAD PHARMACEUTICALS INC | 625,000 | 4,619,000 | 0.82% | ||
| 48 | INTRA CELLULAR THERAPIES INC COM | 115,000 | 4,464,000 | 0.79% | ||
| 49 | OMNICELL COM COM | 128,537 | 4,400,000 | 0.78% | ||
| 50 | ZELTIQ AESTHETICS INCORPORATED | 160,000 | 4,373,000 | 0.78% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-006640, filed 2016.08.01).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
